Things to Know About Idelalisib By Tom Henry – CLL Patient and Pharmacist Idelalisib (eye-del-a-lis-ib), which is marketed under the tradename of Zydelig® in the United... March 28, 2018TreatmentBy clladm1n
New Formulation of Imbruvica (ibrutinib) – Commentary Dr. Furman has been involved in the development of ibrutinib since its very earliest trials. This discussion was triggered by the... March 27, 2018TreatmentBy Todd Dennison
Things to Know About Venetoclax When most of us think of a pharmacist we think of them primarily in the role of retail pharmacy, the... December 28, 2017TreatmentBy clladm1n
One Man’s Opinion: Dr. Rick Furman on the Diminished Role of FCR in treating CLL Dr. Rick Furman of Weill-Cornell answers your questions in our ASK THE DOCTOR feature in our quarterly newsletters, responds to... December 5, 2017TreatmentBy Todd Dennison
Things to Know About Ibrutinib By Tom Henry – CLL Patient and Pharmacist Ibrutinib (eye-broo-ti-nib), which is marketed under the tradename of Imbruvica® in the... September 27, 2017TreatmentBy clladm1n
The Role of the Pharmacist in CLL When most of us think of a pharmacist we think of them primarily in the role of retail pharmacy, the... June 27, 2017The Basics, TreatmentBy Brian Koffman
Steroids: Short-Term Use and the Increased Risk of Serious Complications: Correlation versus Causation (Part 3) Introduction This is the last of a three-part series on the risks and benefits of steroids in CLL. This section reviews a... May 9, 2017TreatmentBy Todd Dennison
Steroids: The Downside (Part 2) In the first of our three part series on the use of steroids in CLL, I explained what corticosteroids are... May 2, 2017TreatmentBy Todd Dennison
Steroids in Chronic Lymphocytic Leukemia (Part 1) This is the first of a three-part series on the use of steroids in chronic lymphocytic leukemia (CLL). In this part,... April 25, 2017TreatmentBy Todd Dennison
Combination Therapies: Dr. Jennifer Brown Discusses the Evolving Treatment Paradigm for CLL Dr. Jennifer Brown from Dana-Farber in Boston discusses in this pithy, less than one minute long video the possible next... March 21, 2017TreatmentBy Todd Dennison
